Talimogene laherparepvec for treating unresectable metastatic melanoma

Final appraisal determination

Final appraisal determination document (PDF 306 KB)

Committee papers (PDF 3.81 MB)

Draft guidance: 508

Committee papers (PDF 11.15 MB)

Appraisal consultation document (PDF 417 KB)

Final scope (PDF 158 KB)

Final matrix (PDF 89 KB)

Equalities impact assessment (PDF 115 KB)

Melanoma (metastatic) - talimogene laherparepvec: draft scope for consultation (pre-referral) - November 2014 (PDF 109 KB)

Melanoma (metastatic) - talimogene laherparepvec: provisional matrix (pre-referral) - November 2014 (PDF 101 KB)